Citations

Clear

3942 citation(s) found for "To, Van".

Pulmonary Biodistribution of Platelet-Derived Regenerative Exosomes in a Porcine Model
Rizzo, Skylar A. , Bagwell, Monique S , Schiebel, Paige , Rolland, Tyler , Mahlberg, Ryan , Witt, Tyra A. , Nagel, Mary, Stalboerger, Paul G., Rolland, Tyler J , Mahlberg, Ryan C , Nagel, Mary E, Bagwell, Monique , Nagel, Mary E., Behfar, Atta

Mayo Clinic

International Journal of Molecular Sciences | February 26, 2024 | Volume: 25 | Issue: 5 | Pages: 2642

10.3390/ijms25052642 | PMID 38473889 Get It

The purpose of this study was to evaluate the biodistribution of a platelet-derived exosome product (PEP), previously shown to promote regeneration in the setting of wound healing, in a porcine model delivered through various approaches. Exosomes were labeled with DiR far-red lipophilic dye to track and quantify exosomes in tissue, following delivery via intravenous, pulmonary artery balloon catheter, or nebulization in sus scrofa domestic pigs. Following euthanasia, far-red dye was detected by Xenogen IVUS imaging, while exosomal protein CD63 was detected by Western blot and immunohistochemistry. Nebulization and intravenous delivery both resulted in global uptake of exosomes within the lung parenchyma. However, nebulization resulted in the greatest degree of exosome uptake. Pulmonary artery balloon catheter-guided delivery provided the further ability to localize pulmonary delivery. No off-target absorption was noted in the heart, spleen, or kidney. However, the liver demonstrated uptake primarily in nebulization-treated animals. Nebulization also resulted in uptake in the trachea, without significant absorption in the esophagus. Overall, this study demonstrated the feasibility of pulmonary delivery of exosomes using nebulization or intravenous infusion to accomplish global delivery or pulmonary artery balloon catheter-guided delivery for localized delivery.
Examining amyloid reduction as a surrogate endpoint through latent class analysis using clinical trial data for dominantly inherited Alzheimer's disease
Wang, Guoqiao , Li, Yan , Xiong, Chengjie , Gordon, Brian A. , Hassenstab, Jason , Aschenbrenner, Andrew J. , Clifford, David B. , Libre‐Guerra, Jorge J., Shi, Xinyu , Mummery, Catherine J. , Dyck, Christopher H. van , Day, Gregg, Ringman, John M. , Fox, Nick C. , Bittner, Tobias , Team, for the DIAN‐TU Study, Day, Gregory S. , Gordon, Brian A , Day, Gregory S , Xiong, Chengjie , Fox, Nick C , Hassenstab, Jason , Aschenbrenner, Andrew J , Xiong, Chengjie , Benzinger, Tammie L.S. , McDade, Eric , Lah, James J. , Honig, Lawrence S. , Day, Gregg, Brooks, William S. , Suzuki, Kazushi , Jucker, Mathias , Delmar, Paul , Bateman, Randall J. , Team, for the DIAN‐TU Study

Mayo Clinic

Alzheimer's & Dementia | February 24, 2024 | Volume: 20 | Issue: 4 | Pages: 2698-2706

10.1002/alz.13735 | PMID 38400532 Get It

AbstractINTRODUCTIONIncreasing evidence suggests that amyloid reduction could serve as a plausible surrogate endpoint for clinical and cognitive efficacy. The double‐blind phase 3 DIAN‐TU‐001 trial tested clinical and cognitive declines with increasing doses of solanezumab or gantenerumab.METHODSWe used latent class (LC) analysis on data from the Dominantly Inherited Alzheimer Network Trials Unit 001 trial to test amyloid positron emission tomography (PET) reduction as a potential surrogate biomarker.RESULTSLC analysis categorized participants into three classes: amyloid no change, amyloid reduction, and amyloid growth, based on longitudinal amyloid Pittsburgh compound B PET standardized uptake value ratio data. The amyloid‐no‐change class was at an earlier disease stage for amyloid amounts and dementia. Despite similar baseline characteristics, the amyloid‐reduction class exhibited reductions in the annual decline rates compared to the amyloid‐growth class across multiple biomarker, clinical, and cognitive outcomes.DISCUSSIONLC analysis indicates that amyloid reduction is associated with improved clinical outcomes and supports its use as a surrogate biomarker in clinical trials.Highlights We used latent class (LC) analysis to test amyloid reduction as a surrogate biomarker. Despite similar baseline characteristics, the amyloid‐reduction class exhibited remarkably better outcomes compared to the amyloid‐growth class across multiple measures. LC analysis proves valuable in testing amyloid reduction as a surrogate biomarker in clinical trials lacking significant treatment effects.
Proton PBS Planning Techniques, Robustness Evaluation, and OAR Sparing for the Whole-Brain Part of Craniospinal Axis Irradiation
Matysiak, W , Landeweerd, Marieke C., Bannink, Agata , Weide, Hiska L. van der , Brouwer, Charlotte L. , Langendijk, Johannes A. , Both, Stefan , Maduro, John H. , Matysiak, Witold P , van der Weide, Hiska L , Gawryszuk, A.

Mayo Clinic

Cancers | February 23, 2024 | Volume: 16 | Issue: 5 | Pages: 892

10.3390/cancers16050892 | PMID 38473254 Get It

Proton therapy is a promising modality for craniospinal irradiation (CSI), offering dosimetric advantages over conventional treatments. While significant attention has been paid to spine fields, for the brain fields, only dose reduction to the lens of the eye has been reported. Hence, the objective of this study is to assess the potential gains and feasibility of adopting different treatment planning techniques for the entire brain within the CSI target. To this end, eight previously treated CSI patients underwent retrospective replanning using various techniques: (1) intensity modulated proton therapy (IMPT) optimization, (2) the modification/addition of field directions, and (3) the pre-optimization removal of superficially placed spots. The target coverage robustness was evaluated and dose comparisons for lenses, cochleae, and scalp were conducted, considering potential biological dose increases. The target coverage robustness was maintained across all plans, with minor reductions when superficial spot removal was utilized. Single- and multifield optimization showed comparable target coverage robustness and organ-at-risk sparing. A significant scalp sparing was achieved in adults but only limited in pediatric cases. Superficial spot removal contributed to scalp V30 Gy reduction at the expense of lower coverage robustness in specific cases. Lens sparing benefits from multiple field directions, while cochlear sparing remains impractical. Based on the results, all investigated plan types are deemed clinically adoptable.
Assessing the Quality of Recruitment Information on Skull Base Surgical Fellowship Program Websites
Sung, Hana, Ton, Emily, Dousse, Dontre', Carlson, Matthew L. , Link, Michael J., Graffeo, Christopher S. , Brown, Nolan J. , Pennington, Zach , Gendreau, Julian , Agazzi, Siviero , Link, Michael J. , Gompel, Jamie J. Van

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | February 21, 2024 | Volume: 85 | Issue: S 01 | Pages: S1-S398

10.1055/s-0044-1780375 Get It

Outcomes of Orbit-Sparing Treatment in Olfactory Neuroblastoma with Orbital Involvement: A Retrospective Cohort Study
Graves, Jeffrey P., Stokken, Janalee K., Celda, María Peris, Link, Michael J., Moore, Eric J. , Choby, Garrett, Bauman, Megan M. J. , Pinheiro‐Neto, Carlos , Gompel, Jamie J. Van

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | February 21, 2024 | Volume: 85 | Issue: S 01 | Pages: S1-S398

10.1055/s-0044-1780316 Get It

Machine Learning-Based Model to Predict Long-Term Tumor Control and Additional Interventions following Pituitary Surgery for Cushing’s Disease
Atkinson, John L. D., Meyer, Fredric B. , Link, Michael J. , Pollock, Bruce E. , Celda, María Peris, Bydon, Mohamad , Davidge‐Pitts, Caroline , Erickson, Dana , Sáez-Alegre, Miguel , Shinya, Yuki , Ghaith, Abdul Karim , Pinheiro‐Neto, Carlos , Bancos, Irina , Herndon, Justine , Bon‐Nieves, Antonio , Hong, Sukwoo , Morshed, Ramin A. , Moussalem, Charbel K. , Gompel, Jamie J. Van

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | February 21, 2024 | Volume: 85 | Issue: S 01 | Pages: S1-S398

10.1055/s-0044-1780278 Get It

Combined Approaches to Management of Petroclival Meningiomas: Systematic Review of Indications and Approach Selection
Kuo, Cathleen C. , Douse, Dontre’ M. , Carlson, Matthew L. , Brown, Nolan J. , Gendreau, Julian , Morshed, Ramin A. , Gompel, Jamie J. Van

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | February 21, 2024 | Volume: 85 | Issue: S 01 | Pages: S1-S398

10.1055/s-0044-1780254 Get It

Surgical Approaches to Resection of Olfactory Groove Meningiomas: Comparative Meta-analysis of the Endoscopic Endonasal versus Transcranial Approaches
Mehkri, Yusuf , Kuo, Cathleen C. , Chakravarti, Sachiv , Brown, Nolan J. , Pennington, Zach , Gendreau, Julian , Gompel, Jamie J. Van

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | February 21, 2024 | Volume: 85 | Issue: S 01 | Pages: S1-S398

10.1055/s-0044-1780251 Get It

Stereotactic Radiosurgery versus Serial Observation for Incidentally Diagnosed Skull Base Meningiomas
Pollock, Bruce E. , Link, Michael J. , Peris‐Celda, Maria , Brown, Nolan J. , Pennington, Zach , Morshed, Ramin A. , Gendreau, Julian , Ransom, Ryan C. , Gompel, Jamie J. Van

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | February 21, 2024 | Volume: 85 | Issue: S 01 | Pages: S1-S398

10.1055/s-0044-1780248 Get It

New Approach—Biportal Endoscopic Transfrontal Sinus Approach: A Novel Minimally Invasive Approach to the Anterior Cranial Fossa: Cadaveric Feasibility Study
Sáez-Alegre, Miguel , Link, Michael J., Peris‐Celda, Maria , Jean, Walter C. , Pinheiro‐Neto, Carlos , Morshed, Ramin A. , Gompel, Jamie J. Van

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | February 21, 2024 | Volume: 85 | Issue: S 01 | Pages: S1-S398

10.1055/s-0044-1780189 Get It